Quality control of Yellow Fever vaccines performed by Control Authorities prior to marketing vaccines batches requires in vitro potency assays. The two currently available methods are the plaque formation assay and the cytopathic effect assay based on the use of porcine kidney PS cells or monkey kidney Vero cells. Among several sources of variation in virus titration, the cell systems are considered as important issues and Quality Assurance strongly recommends working with cell banks from certified suppliers. The aim of our study was to compare the behaviour and the sensitivity of three Vero cell sources obtained from ATCC, WHO and EP used at different passage levels in a plaque formation test. The conclusion of this work was that the yellow fever live attenuated virus titration, adapted in Vero cell lines appeared as a reliable method applicable for routine in vitro potency assay. The comparison of Vero cell lines, originated from three different sources, showed that they could be equally used as substrates by laboratories having the basic facility of cell culture, without influence on the final viral titre.
[1]
J. Spaltro,et al.
Virus assay methods: accuracy and validation.
,
1998,
Biologicals : journal of the International Association of Biological Standardization.
[2]
A. Barrett.
Yellow fever vaccines.
,
1997,
Biologicals : journal of the International Association of Biological Standardization.
[3]
S. Kumar,et al.
A rapid test for measuring the infectivity of Yellow Fever vaccine.
,
1995,
Vaccine.
[4]
J. Vliet.
Assessment of an end-point microassay for yellow fever vaccine.
,
1990
.
[5]
V. Seagroatt,et al.
A W.H.O. collaborative study of in vitro and in vivo methods for the assay of yellow fever vaccines.
,
1983,
Journal of biological standardization.
[6]
J. S. Porterfield,et al.
A simple micro-culture method for the study of group B arboviruses.
,
1969,
Bulletin of the World Health Organization.